TECHNOLOGY
Crusoe abandons $1.25B plan to use Boom turbines at AI data centers
TechCrunchFriday, September 25, 2026 at 11:11 PM
RedScroll Brief
Boom Supersonic CEO Blake Scholl said the company's new stationary power plants were no longer in Crusoe's near-term plans.
RedScroll Signal
- Impact
- High
- Category
- Technology
- Market relevance
- Moderate
- Why it matters
- Technology shifts change how people work, communicate, and build — often faster than policy can follow. Boom Supersonic CEO Blake Scholl said the company's new stationary power plants were no longer in Crusoe's near-term plans. Secondary effects may show up in markets and supply chains linked to Crusoe and Boom.
Desk copy
RedScroll Briefing
Extractive editorial brief — not a reprint of the original
What happened
Boom Supersonic CEO Blake Scholl said the company's new stationary power plants were no longer in Crusoe's near-term plans.
Why it matters
Technology shifts change how people work, communicate, and build — often faster than policy can follow.
Background
TechCrunch reported on this under technology. RedScroll surfaces the signal with an extractive brief — not a reprint of the original article. Read the source for full reporting.
Timeline
TechCrunch published: Crusoe abandons $1.25B plan to use Boom turbines at AI data centers
Story is in today’s RedScroll edition. Follow the original source for updates.
Economic impact
Secondary effects may show up in markets and supply chains linked to Crusoe and Boom.
More on
Related stories
- AI was supposed to hit new grads hard. So far, unemployment data says otherwise.
Ars TechnicaTECHNOLOGY
- Waymo is scaling fast: Here’s what the fleet data shows
TechCrunchTECHNOLOGY
- The Download: the Pentagon’s AI-powered lie detector and young organ limits
MIT Technology ReviewTECHNOLOGY
- The Download: a bid to scrap the virtual wall and AI hits Climate Week
MIT Technology ReviewTECHNOLOGY
- The Download: India’s smart glasses menace and AI’s trillion-dollar gamble
MIT Technology ReviewTECHNOLOGY
- Can Trump ever be wrong? His pick to lead FDA refused to say.
Ars TechnicaTECHNOLOGY
Source
TechCrunch
Original reporting by TechCrunch. RedScroll provides an extractive briefing only.